[1]Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy. Sun, Guo-Rong,Zhang, Yan-Ping,Zhou, Lin-Yi,Lv, Hong-Chao,Zhang, Feng,Li, Kai,Gao, Yu-Long,Qi, Xiao-Le,Cui, Hong-Yu,Wang, Yong-Qiang,Gao, Li,Pan, Qing,Wang, Xiao-Mei,Liu, Chang-Jun. 2017

[2]Depression of Vaccinal Immunity to Marek's Disease by Infection with Chicken Infectious Anemia Virus. Zhang, Yankun,Cui, Ning,Han, Ni,Wu, Jiayan,Cui, Zhizhong,Su, Shuai,Zhang, Yankun,Cui, Ning,Han, Ni,Wu, Jiayan,Su, Shuai,Zhang, Yankun,Cui, Ning,Han, Ni,Wu, Jiayan,Su, Shuai,Cui, Ning. 2017

[3]A Tiny RNA that Packs a Big Punch: The Critical Role of a Viral miR-155 Ortholog in Lymphomagenesis in Marek's Disease. Zhuang, Guoqing,Sun, Aijun,Teng, Man,Luo, Jun,Luo, Jun. 2017

[4]Pathogenic characteristics of Marek's disease virus field strains prevalent in China and the effectiveness of existing vaccines against them. Zhang, Yan-ping,Wang, Xiao-mei,Zhang, Yan-ping,Li, Zhi-jie,Bao, Ke-yan,Lv, Hong-chao,Gao, Yu-long,Gao, Hong-lei,Qi, Xiao-le,Cui, Hong-yu,Wang, Yong-qiang,Ren, Xian-gang,Wang, Xiao-mei,Liu, Chang-jun.

[5]Protection of Chickens against Very Virulent Marek's Disease Virus (MDV) by an Infectious Clone of Meq-Null MDV Vaccination. Cui, Ning,Su, Shuai,Cui, Zhizhong,Sun, Peng,Li, Yanpeng,Zhu, Hongfei,Ding, Jiabo,Kang, Mengjiao.

[6]Comparison of different sites in recombinant Marek's disease virus for the expression of green fluorescent protein. Liu, Yongzhen,Li, Kai,Cui, Hongyu,Gao, Li,Liu, Changjun,Zhang, Yanping,Gao, Yulong,Wang, Xiaomei.

[7]Isolation and full-genome sequence of two reticuloendotheliosis virus strains from mixed infections with Marek's disease virus in China. Bao, Ke-yan,Zhang, Yan-ping,Zheng, Hui-wen,Lv, Hong-chao,Gao, Yu-long,Wang, Jing-fei,Gao, Hong-lei,Qi, Xiao-le,Cui, Hong-yu,Wang, Yong-qiang,Ren, Xian-gang,Wang, Xiao-mei,Liu, Chang-jun,Wang, Xiao-mei.

[8]Deletion of the BAC sequences from recombinant meq-null Marek's disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD. Su, S.,Cui, N.,Sun, P.,Cui, Z.,Li, J.,Li, H.,Li, Y..

[9]Evaluation of two strains of Mareles disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus. Li, Kai,Liu, Yongzhen,Liu, Changjun,Gao, Li,Gao, Yulong,Zhang, Yanping,Cui, Hongyu,Qi, Xiaole,Zhong, Li,Wang, Xiaomei.

[10]A BAC clone of MDV strain GX0101 with REV-LTR integration retained its pathogenicity. Sun AiJun,Cui ZhiZhong,Lawrence, Petherbridge,Zhao YuGuang,Nair, Venugopal K.,Li YanPeng. 2009

[11]A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD. Su, Shuai,Cui, Ning,Chen, Zimeng,Wang, Yixin,Duan, Luntao,Cui, Zhizhong,Zhou, Yu,Li, Yanpeng,Ding, Jiabo.

[12]Development of a rapid and specific loop-mediated isothermal amplification detection method that targets Marek's disease virus meq gene. Wei, Xiuying,Shi, Xingming,Zhao, Yan,Zhang, Jing,Wang, Mei,Liu, Changjun,Cui, Hongyu,Hu, Shunlei,Quan, Yanming,Chen, Hongyan,Wang, Yunfeng,Wei, Xiuying. 2012

[13]Sequence analysis of the Meq gene in the predominant Marek's disease virus strains isolated in China during 2006-2008. Zhang, Yan-ping,Liu, Chang-jun,Zhang, Feng,Shi, Weisong,Li, Jingmei. 2011

[14]A Chinese Variant Marek's Disease Virus Strain with Divergence between Virulence and Vaccine Resistance. Sun, Guo-rong,Zhang, Yan-ping,Lv, Hong-chao,Zhou, Lin-yi,Cui, Hong-yu,Gao, Yu-long,Qi, Xiao-le,Wang, Yong-qiang,Li, Kai,Gao, Li,Pan, Qing,Wang, Xiao-mei,Liu, Chang-jun. 2017

[15]Isolation and biologic characteristics of a serotype 1 Marek's disease virus from chickens in Fuzhou. Cheng, Y,Li, Y,Hu, Q,Chen, S. 1996

[16]Putative roles as oncogene or tumour suppressor of the Mid-clustered microRNAs in Gallid alphaherpesvirus 2 (GaHV2) induced Marek's disease lymphomagenesis. Teng, Man,Wu, Zi-Xiang,Wu, Run,Teng, Man,Zhao, Pu,Dang, Lu,Li, Hui-Zhen,Ma, Sheng-Ming,Luo, Jun,Yu, Zu-Hua,Ma, Sheng-Ming,Luo, Jun,Zhuang, Guo-Qing,Cui, Zhi-Zhong,Zhang, Gai-Ping,Zhang, Gai-Ping.

[17]Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice. Chen, Jia,Li, Zhong-Yuan,Huang, Si-Yang,Song, Hui-Qun,Zhou, Dong-Hui,Zhu, Xing-Quan,Chen, Jia,Zhu, Xing-Quan,Petersen, Eskild,Petersen, Eskild. 2014

[18]CpG DNA enhances the immune responses elicited by the DNA vaccine against foot-and-mouth disease virus in guinea pigs. Li, GJ,Li, YJ,Yan, WY,Xu, QX,Wu, YQ,Xie, Y,You, YJ,Zheng, ZX. 2001

[19]Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Zhang, Nian-Zhang,Xu, Ying,Wang, Meng,Chen, Jia,Huang, Si-Yang,Zhu, Xing-Quan,Xu, Ying,Petersen, Eskild,Huang, Si-Yang,Zhu, Xing-Quan. 2015

[20]Immune Effect of Newcastle Disease Virus DNA Vaccine with C3d as a Molecular Adjuvant. Zhao, Kai,Duan, Xutong,Hao, Lianwei,Wang, Xiaohua,Zhao, Kai,Duan, Xutong,Wang, Yunfeng. 2017